- cafead Sep 19, 2024 at 09:32: PM
via A new company born out of research done by top Harvard genetic scientist George Church is promising to “revolutionize cell therapy.”
The company, GC Therapeutics, announced its launch Thursday with $75 million in financing from investors including Cormorant Asset Management and Mubadala Capital. Its board and list of advisers includes John Maraganore, the founding CEO of Alnylam Pharmaceuticals, and Steve Paul, the former CEO of Karuna Therapeutics, along with three executives representing investors.
article source
The company, GC Therapeutics, announced its launch Thursday with $75 million in financing from investors including Cormorant Asset Management and Mubadala Capital. Its board and list of advisers includes John Maraganore, the founding CEO of Alnylam Pharmaceuticals, and Steve Paul, the former CEO of Karuna Therapeutics, along with three executives representing investors.
article source